Prokineticin Receptor 2 (PROKR2) (C-Term) Peptide
Quick Overview for Prokineticin Receptor 2 (PROKR2) (C-Term) Peptide (ABIN982249)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- CFVTVKNNTM KYFKKMMLLH WRPSQRGSKS SADLDLRTNG VPTTEEVDCI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PROKR2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Prokineticin Receptor 2 (PROKR2)
-
Background
-
Prokineticins are secreted proteins that can promote angiogenesis and induce strong gastrointestinal smooth muscle contraction. The protein encoded by this gene is an integral membrane protein and G protein-coupled receptor for prokineticins. The encoded protein is similar in sequence to GPR73, another G protein-coupled receptor for prokineticins.
Alias Symbols: GPR73L1, GPR73b, GPRg2, KAL3, PKR2, dJ680N4.3
Protein Interaction Partner: PROKR2
Protein Size: 384 -
Molecular Weight
- 44 kDa
-
Gene ID
- 128674
-
NCBI Accession
- NM_144773, NP_658986
-
UniProt
- Q8NFJ6
Target
-